Page last updated: 2024-11-05

troglitazone and Esophageal Neoplasms

troglitazone has been researched along with Esophageal Neoplasms in 4 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, Y1
Shimada, Y1
Itami, A1
Ito, T1
Kawamura, J1
Kawabe, A1
Kaganoi, J1
Maeda, M1
Watanabe, G1
Imamura, M1
Takashima, T2
Fujiwara, Y2
Hamaguchi, M1
Sasaki, E1
Tominaga, K1
Watanabe, T1
Oshitani, N1
Higuchi, K2
Arakawa, T2
Yano, Y1
Hasuma, T1
Otani, S1
Rumi, MA1
Sato, H1
Ishihara, S1
Ortega, C1
Kadowaki, Y1
Kinoshita, Y1

Other Studies

4 other studies available for troglitazone and Esophageal Neoplasms

ArticleYear
Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma.
    European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:15

    Topics: Alitretinoin; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blotting, Weste

2003
Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Oncology reports, 2005, Volume: 13, Issue:4

    Topics: Antibodies, Monoclonal; Apoptosis; Barrett Esophagus; Biopsy; Bisbenzimidazole; Blotting, Western; C

2005
PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity.
    International journal of oncology, 2001, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell

2001
Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands.
    The Journal of laboratory and clinical medicine, 2002, Volume: 140, Issue:1

    Topics: Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Chromans; DNA Replication; Esophageal Neoplasms

2002